AI주식인사이트AI Stock Insight
C

아미노로직스

074430KOSDAQ기초 의약물질 제조업

50.5 / 100

Reference Date: 2026-07-24

Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 2.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

AmiNoLogics primarily engages in the manufacturing and sales of raw pharmaceutical materials and amino acid derivative compounds, supplying treatments for conditions such as stroke, eye diseases, and dermatitis to domestic pharmaceutical companies. The pharmaceutical industry operates under strict government regulations, intense competition, and a focus on generic drug development.

Number of Employees

41people

Average Salary

69.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
26.30Industry Average 25.443.0Point

Higher than industry avg (caution)

PBR
1.65Industry Average 1.262.5Point

Higher than industry avg (caution)

ROE
6.54Industry Average -6.033.5Point

Well below industry avg

Debt Ratio
1.09Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.8% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲9.8% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 2.7% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (19%, downtrend)

Current 1,052Won52-week high 1,83852-week low 863
1-month return2.0Point

1m -2.14% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-13
  • Neutral주식등의대량보유상황보고서(일반)2026-07-13
  • Neutral주식등의대량보유상황보고서(일반)2026-07-10